BNP Paribas Asset Management’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-250,967
Closed -$8.98M 1092
2014
Q4
$8.98M Buy
250,967
+49,047
+24% +$1.46M 0.07% 330
2014
Q3
$5.25M Buy
201,920
+11,759
+6% +$338K 0.04% 415
2014
Q2
$6.29M Buy
190,161
+12,818
+7% +$370K 0.05% 405
2014
Q1
$5.31M Sell
177,343
-38,969
-18% -$1.34M 0.04% 419
2013
Q4
$6.57M Buy
216,312
+75,387
+53% +$2.08M 0.05% 346
2013
Q3
$4.48M Sell
140,925
-237,175
-63% -$5.44M 0.03% 400
2013
Q2
$5.71M Buy
+378,100
New +$5.24M 0.04% 380

Other funds holding NPSP

BNP Paribas Asset Management's NPSP Position: Q1 2015 in Review

BNP Paribas Asset Management sold out of NPS PHARMACEUTICALS INC (NPSP) in Q1 2015, closing a stake of 250,967 shares — an estimated $8.98M sold.

BNP Paribas Asset Management first reported a position in NPSP in Q2 2013 and held it in 7 quarters. The position peaked at $8.98M in Q4 2014. 1 fund tracked by Wall St. Rank holds NPSP as of Q1 2015.

  • BNP Paribas Asset Management reported no remaining NPS PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • BNP Paribas Asset Management sold 250,967 NPS PHARMACEUTICALS INC shares in Q1 2015, an estimated $8.98M.
  • BNP Paribas Asset Management first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • BNP Paribas Asset Management's NPS PHARMACEUTICALS INC position peaked at $8.98M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q1 2015.

Based on BNP Paribas Asset Management's 13F filing for Q1 2015, filed 12 May 2015.